These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21293802)

  • 21. Evaluation and performance characteristics of the automated coagulation analyzer ACL TOP.
    Appert-Flory A; Fischer F; Jambou D; Toulon P
    Thromb Res; 2007; 120(5):733-43. PubMed ID: 17275069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole blood coagulation analyzers.
    Health Devices; 1997 Aug; 26(8):296-332. PubMed ID: 9283920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 96-well microfiltration assay for measurement of total clottable fibrinogen.
    Dempfle CE; Keller A; Argirion S; Heene DL
    Thromb Haemost; 1999 Feb; 81(2):264-7. PubMed ID: 10064004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clot formation in canine whole blood as measured by rotational thromboelastometry is influenced by sample handling and coagulation activator.
    Smith SA; McMichael M; Galligan A; Gilor S; Hoh CM
    Blood Coagul Fibrinolysis; 2010 Oct; 21(7):692-702. PubMed ID: 20739876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clotting, activated partial thromboplastin and coagulation times in monitoring heparin therapy.
    Kurec AS; Morris MW; Davey FR
    Ann Clin Lab Sci; 1979; 9(6):494-500. PubMed ID: 518012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical value of a new method of therapeutic control of heparin].
    Pizzuto J; Garcia S; de la Paz Reyna M; Morales MR; Avilés A; Zavala B; Ponce L; Gaos C
    Arch Inst Cardiol Mex; 1978; 48(2):373-86. PubMed ID: 666447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Right or wrong sample received for coagulation testing? Tentative algorithms for detection of an incorrect type of sample.
    Lippi G; Salvagno GL; Adcock DM; Gelati M; Guidi GC; Favaloro EJ
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):132-8. PubMed ID: 19220524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A step change in oral anticoagulation: lack of coagulation monitoring with ximelagatran.
    Carlsson SC; Schulman S
    Semin Vasc Med; 2005 Aug; 5(3):259-65. PubMed ID: 16123913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Activated thromboplastin time, plasma heparin and plasma fibrinogen using the Fibrintimer 10].
    Khayat MC; Laforet F; Khayat A; Derlon A; Lequerrec A; Thomas M
    Ann Biol Clin (Paris); 1988; 46(8):696-700. PubMed ID: 3218791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reduced anticoagulant effect of fondaparinux at low antithrombin levels.
    Dempfle CE; Eichner J; Suvajac N; Ahmad-Nejad P; Neumaier M; Borggrefe M
    Anesth Analg; 2009 Sep; 109(3):712-6. PubMed ID: 19690236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alkaloids of tobacco and blood coagulation: effect of nicotine on thrombin and fibrinogen.
    Singh JM; Singh MD
    Clin Toxicol; 1975; 8(1):43-52. PubMed ID: 1137933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to 'Multicenter evaluation of a bilayer polymer blood coagulation tube for coagulation testing: effect on routine hemostasis test results and on plasma levels of coagulation activation markers'.
    Polack B
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):709. PubMed ID: 17890964
    [No Abstract]   [Full Text] [Related]  

  • 35. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
    Exner T; Low J
    Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring the effect of heparin bolus during percutaneous coronary angioplasty (PTCA): assessment of three bedside coagulation monitors.
    Hézard N; Metz D; Potron G; Nazeyrollas P; Maes D; Droulle C; Mulpas MC; Elaerts J; Nguyen P
    Thromb Haemost; 1998 Nov; 80(5):865-6. PubMed ID: 9843190
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of three methods for measuring factor VIII levels in plasma.
    Chandler WL; Ferrell C; Lee J; Tun T; Kha H
    Am J Clin Pathol; 2003 Jul; 120(1):34-9. PubMed ID: 12866370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices.
    Ganter MT; Hofer CK
    Anesth Analg; 2008 May; 106(5):1366-75. PubMed ID: 18420846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.